TVGN
TVGN
NASDAQ · Biotechnology

Tevogen Bio Holdings Inc

$5.77
+0.03 (+0.52%)
As of Jul 4, 10:52 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +263.3% upside
Low Target $15.05
Average Target $20.96
High Target $24.54
Current Price $5.77
Current
$5.77
Target
$20.96
$15.05 $20.96 avg $24.54
Scenario Analysis
Bear Case
$15.05
160.8%
Low target
Base Case
$20.96
+263.3%
Avg target
Bull Case
$24.54
+325.3%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$71.00
-91.9% from high
52-Week Low
$4.14
+39.5% from low
Target vs 52W High
$20.96
-70.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 -1.3%
AMGN
Amgen Inc
Hold 44 50% $190.87 -49.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +176.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -17.0%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -88.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -67.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.7%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -48.8%